Industry information

Zeno Technology received over 10 million yuan in angel round financing

A few days ago, Zeno Technology (Fujian) Co.

Zeno Technology mainly uses a new generation of gene editing technology to carry out gene-directed transformation of chassis microorganisms such as Escherichia coli and yeast, and industrially amplifies the products of these bacteria through fermentation, separation and other processes to produce HMO and new microbial pigments

In 2017, HMO was first approved by the EU to enter the new food resource catalogue, and has since been used as an additive in infant formula milk powder by European and American countries

It is reported that in October 2021, the National Food Safety Risk Assessment Center has completed the safety and necessity demonstration of 2'-fucosyllactose, the ingredient with the highest content in HMO, and began to solicit public opinions

In terms of commercialization, taking into account the differences in policies at home and abroad, Zeno Technology currently mainly cooperates with new consumer enterprises in cross-border e-commerce to supply HMO to foreign functional food enterprises

(its text)

U.

Recently, BIO-CAT Microbials, a manufacturer of micro-ecological preparations, announced that it will invest 35 million US dollars (about 220 million yuan) for the expansion of the factory, which will increase the existing factory land from 5,000 square meters to 9,300 square meters.

Founded in 2004, BIO-CAT Microbials is a comprehensive solution provider of microbial inoculants located in Virginia, USA, providing customized microbial inoculum production services for downstream customers in human, animal and plant health care, and in the development of strains.

The renovation and expansion plan will be completed in 2023, and by adding advanced fermentation equipment, quality control laboratories and R&D centers, the company's fermentation capacity will be increased by 400%, and at the same time, it will be able to meet the customized services of small and medium-sized fermentation levels for downstream customers

At present, the company mainly produces a series of Bacillus powders, and at the same time reserves 13 high-performance Bacillus strains

(Ke Xin)

"China Food News" (06 edition on March 21, 2022)

　　(Editor-in-charge: Yang Xiaojing)